Book a demo

Chemical intelligence powered by cypris.ai

Glutathionylspermidine

(2S)-2-amino-5-[[(2R)-1-[[2-[3-(4-aminobutylamino)propylamino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoic acid · also: N'-Glutathionylspermidine disulfide · N1-(gamma-L-glutamyl-L-cysteinyl-glycyl)-spermidine · L-gamma-Glutamyl-L-cysteinyl-N-(3-((4-aminobutyl)amino)propyl)glycinamide · (2S)-2-amino-5-(((2R)-1-((2-(3-(4-aminobutylamino)propylamino)-2-oxoethyl)amino)-1-oxo-3-sulfanylpropan-2-yl)amino)-5-oxopentanoic acid · (2S)-2-amino-4-(((1R)-1-((((3-((4-aminobutyl)amino)propyl)-C-hydroxycarbonimidoyl)methyl)-C-hydroxycarbonimidoyl)-2-sulfanylethyl)-C-hydroxycarbonimidoyl)butanoic acid

FormulaC17H34N6O5S
Mol. weight434.556
PubChem CID440772
InChIKeyNEDQLXHBVHSKNV-STQMWFEESA-N
SMILESC(CCNCCCNC(=O)CNC(=O)[C@H](CS)NC(=O)CC[C@@H](C(=O)O)N)CN
41Patents
35Research papers
1Patents - last 3 years
0Papers - last 3 years

Who owns the IP

The organizations most actively patenting around this compound, ranked by referenced patent volume.

#AssigneePatents
1Amgen Inc10
2Icagen Inc6
3University of California3
4Defined Diagnostics LLC2
5The University of Texas System2
6OmniAb Inc1

Explore the full landscape

This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.

Visit Cypris

Where innovation is concentrated

Patent classifications ranked by volume reveal the technical domains with the most active filing.

#CodeAreaPatents
1C12NMicroorganisms, enzymes26
2G01NInvestigating / analysing materials15
3A61KMedicinal preparations11
4A61PTherapeutic activity (drug indications)11
5C40B9
6G21K8
7C12QMeasuring/testing involving enzymes7
8Y10SCross-reference (legacy)7
9C12PFermentation, enzyme processes4
10A01NPreservation of bodies; biocides; pest repellents2

AI mapped opportunity space

This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.

See Cypris in action

Representative patents

The filings that best characterise the patent activity around this compound, most-referenced first.

TitleYearAssignee
Glutathionylspermidine synthetase2001
GLUTATHIONYLSPERMIDINE SYNTHETASE2000
Glutathionylspermidine synthetase2000
GLUTATHIONYLSPERMIDINE SYNTHETASE1999
Glutathionylspermidine synthetase1998

How research activity has moved

Papers published per year for this compound, over the last decade of indexed records.

YearPapers
20161
20171

Who's driving the science

The most-published authors working with this compound, alongside their primary affiliations.

#AuthorAffiliationPapers
1Alan H. FairlambWellcome Trust7
2R. Luise Krauth‐SiegelHeidelberg University6
3Chun‐Hung LinInstitute of Biological Chemistry, Academia Sinica5
4Leopold FlohéUniversity of Padua5
5Marcelo A. CominiInstitut Pasteur de Montevideo4
6Christopher T. WalshHarvard University4
7Mark R. AriyanayagamUniversity of London3
8Shoujun ChenUniversity of Michigan3
9David S. KwonHarvard University3
10Ulrich MengeHelmholtz Centre for Infection Research3

Research leaders

This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.

See Cypris in action

The literature that defines it

The most-cited papers anchoring the scientific record for this compound.

Frequently asked questions

Common questions about this compound's patent and research landscape, answered from the underlying data.

What is the molecular formula and weight of Glutathionylspermidine?

Glutathionylspermidine has the molecular formula C17H34N6O5S and a molecular weight of 434.556 Da.

Which organizations hold the most patents related to Glutathionylspermidine?

Amgen Inc leads with 10 patents, followed by Icagen Inc with 6 patents, and University of California with 3 patents.

What are the most common patent classifications for Glutathionylspermidine-related inventions?

The most frequently used CPC subclass is C12N with 26 patents, followed by G01N with 15 patents, and A61K and A61P each with 11 patents.

Who are the most prolific authors publishing research on Glutathionylspermidine?

Alan H. Fairlamb from Wellcome Trust leads with 7 papers, followed by R. Luise Krauth‐Siegel from Heidelberg University with 6 papers, and Chun‐Hung Lin from Institute of Biological Chemistry, Academia Sinica with 5 papers.

What is the recent patent activity trend for Glutathionylspermidine?

Patent activity peaked in 2016 with 3 patents filed. Over the last 3 years, only 1 patent has been filed (in 2025), with no papers published in that period.

Turn any compound into a complete chemical intelligence landscape

Go beyond static compound data. Cypris resolves identities, patents, papers, and commercial signals into one AI-powered view - so your team can move from a single chemical question to a complete R&D, IP, and market landscape.

Schedule a free trial